Cancer incidence in hypertensives
- 1 April 1987
- Vol. 59 (7) , 1386-1390
- https://doi.org/10.1002/1097-0142(19870401)59:7<1386::aid-cncr2820590726>3.0.co;2-b
Abstract
Cancer incidence was measured over a 5-year period (1978 to 1982) in 4067 hypertensive patients, and 10,366 normotensive patients from general practices in southwestern Ontario. For cancer of all sites an elevated incidence was found among hypertensive patients. The elevation was most pronounced among newly diagnosed hypertensive patients, with hypertension of moderate or greater severity, and for sites that have been described in clinical reports as being capable of producing a rise in blood pressure. It is tentatively concluded that the causal direction is from cancer to hypertension, rather than the reverse. If this conclusion is correct, the associations that have been reported between cancer mortality and hypertension may be due to an effect of blood pressure upon survival from cancer.This publication has 9 references indexed in Scilit:
- Elevated Systolic Blood Pressure as a Predictor of Long-Term Cancer Mortality: Analysis by Site and Histologic Subtype in 10,000 Middle-Aged and Elderly Men2JNCI Journal of the National Cancer Institute, 1986
- SYSTOLIC BLOOD PRESSURE AND CANCER MORTALITY IN AN ELDERLY POPULATIONAmerican Journal of Epidemiology, 1984
- HIGH BLOOD PRESSURE AND 17-YEAR CANCER MORTALITY IN THE WESTERN ELECTRIC HEALTH STUDY1American Journal of Epidemiology, 1981
- Mortality and Morbidity during 13.5 Years' Follow‐up in Relation to Blood PressureActa Medica Scandinavica, 1979
- Glycopeptide Hormones and NeoplasmsNew England Journal of Medicine, 1977
- HYPERTENSION RELATED TO D.N.A. REPAIR SYNTHESIS AND CARCINOGEN UPTAKEThe Lancet, 1975
- REVIEW THE BIOSYNTHESIS OF HORMONES BY NON-ENDOCRINE TUMOURS-A REVIEWJournal of Endocrinology, 1975
- HIGH BLOOD-PRESSURE AND CANCER ?The Lancet, 1975
- HIGH BLOOD-PRESSURE: A RISK FACTOR FOR CANCER MORTALITY ?The Lancet, 1975